Skip to main content
News > News > Cooperation of Oncolytic Herpes Virotherapy and PD-1 Blockade in Murine Rhabdomyosarcoma Models
Our Effort

Open Therapeutics is a major backer of open science and open access efforts.

Open Therapeutics freely provides to science, technology, engineering, and math (STEM) scientists, or another other seriously interested persons, intellectual properties (patents, etc.), grant funding, lab equipment, document development tools, and preprint server in a collaboration platform (Therapoid™).

When the researchers advance the intellectual properties, s/he gains ScienceCoins™; a blockchain-based cryptocurrency.

Social Links
Contact Us Today
PO Box 30085
Cincinnati, OH 45230

+1.513.252.2901

Privacy Policy  ·   Terms of Service (TOS)  ·   Cookie Disclosure  ·   DMCA Policy  ·   EULA

Copyright © 2022 Open Therapeutics | All Rights Reserved